Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Centaur's new NRTs and their use for treating, preventing IBD

Jan. 3, 2000

Japanese labs discover new imidazoles useful for liver disease

Dec. 30, 1999

Byk Gulden compounds exhibit potent anti-H. pylori activity

Dec. 30, 1999

Agents for accelerating peristalsis in development at Dainippon

Dec. 29, 1999

Salix responds to FDA approvable letter and reacquires rights to UC treatment from AstraZeneca

Dec. 29, 1999

Licensing opportunity from NIH: antisense therapy for Crohn's disease

Dec. 28, 1999

Excellent results obtained for Synsorb Cd against CDAD

Dec. 28, 1999

Glaxo Wellcome seeks approval for new IBS treatment in the E.U.

Dec. 23, 1999

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

Isis surprised by disappointing results in Crohn's disease study of ISIS-2302

Dec. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...